IRF6 and breast carcinoma: To address the consequences of low IRF6 and GRHL3 levels in cancer cell lines, we rescued their expression in the breast cancer cell line T47D and in the oral squamous carcinoma cell line SCC-68 (Figure 3A and Supplementary Figure 4).